Venture Capital Archives - Page 9 of 97

BU Study Warns Trump-Era Policies Could Cost Massachusetts Billions Annually

April 29, 2025

Insulet Names Ashley McEvoy as New CEO, Expects to Raise 2025 Revenue Guidance

April 28, 2025

Healthpeak and Hines Partner on Cambridge Point Mixed-Use Development in Cambridge, Massachusetts

April 25, 2025

THIS WEEK'S STORIES

Ankyra Therapeutics Reports Promising Phase 1 Data for IL-12 Drug Conjugate at AACR, Doses First Patient in Combination Trial

April 28, 2025

Knipper Health Expands Executive Leadership Team with Three Senior Appointments

April 22, 2025

Alnylam Wins Key European Regulatory Backing for Vutrisiran in ATTR Amyloidosis with Cardiomyopathy

April 28, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Venture Capital

Verastem Oncology Secures $75 Million Through Private Placement to Advance Cancer Therapies

UPS to Acquire Andlauer Healthcare Group for $1.6 Billion, Expanding Cold Chain Logistics in North America

Breyer Capital Appoints Morgan Cheatham as Partner and Head of Healthcare and Life Sciences

Granite Bio Emerges from Stealth with $100 Million to Advance Novel Immunology Therapies

Nourish Raises $70 Million in Series B to Expand AI-Driven Nutrition Care for Chronic Disease

Most Read

Strand Therapeutics Unveils Promising Preclinical Data for STX-003, a Programmable mRNA Therapy Targeting Solid Tumors

Barth Syndrome Foundation Urges FDA to Act Swiftly on Delayed Elamipretide Decision

Basil Systems Raises $11.5 Million to Accelerate AI-Driven Insights for Life Sciences Industry

Shorla Oncology Secures FDA Approval for First Ready-to-Dilute Multi-Dose Thiotepa Vial to Treat Breast and Ovarian Cancer

EDITOR PICKS

BU Study Warns Trump-Era Policies Could Cost Massachusetts Billions Annually

Insulet Names Ashley McEvoy as New CEO, Expects to Raise 2025 Revenue Guidance

Healthpeak and Hines Partner on Cambridge Point Mixed-Use Development in Cambridge, Massachusetts

THIS WEEK'S STORIES

Ankyra Therapeutics Reports Promising Phase 1 Data for IL-12 Drug Conjugate at AACR, Doses First Patient in Combination Trial

Knipper Health Expands Executive Leadership Team with Three Senior Appointments

Alnylam Wins Key European Regulatory Backing for Vutrisiran in ATTR Amyloidosis with Cardiomyopathy

POPULAR CATEGORY

ABOUT US

FOLLOW US